Cipla
Quarterly Results Analysis [Mar2022]

Cipla is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for Cipla
Please provide your vote to see the results

Cipla Quarterly Results

Consolidated Mar2022
Audited
Dec2021
UnAudited
Sep2021
Audited
Jun2021
UnAudited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
Audited
Jun2020
UnAudited
Revenues ₹5,260 Cr ₹5,479 Cr ₹5,520 Cr ₹5,504 Cr ₹4,606 Cr ₹5,169 Cr ₹5,038 Cr ₹4,346 Cr
Expenses ₹4,511 Cr ₹4,248 Cr ₹4,294 Cr ₹4,158 Cr ₹3,810 Cr ₹3,938 Cr ₹3,862 Cr ₹3,297 Cr
Operating Income ₹750 Cr ₹1,231 Cr ₹1,226 Cr ₹1,346 Cr ₹796 Cr ₹1,231 Cr ₹1,177 Cr ₹1,049 Cr
Other Income ₹64 Cr ₹91 Cr ₹61 Cr ₹65 Cr ₹60 Cr ₹87 Cr ₹53 Cr ₹65 Cr
Interest ₹18 Cr ₹21 Cr ₹38 Cr ₹30 Cr ₹27 Cr ₹48 Cr ₹39 Cr ₹46 Cr
Depreciation ₹290 Cr ₹247 Cr ₹253 Cr ₹261 Cr ₹285 Cr ₹248 Cr ₹265 Cr ₹269 Cr
Profit Before Tax ₹448 Cr ₹1,054 Cr ₹996 Cr ₹996 Cr ₹544 Cr ₹1,021 Cr ₹926 Cr ₹799 Cr
Profit After Tax ₹377 Cr ₹759 Cr ₹712 Cr ₹712 Cr ₹416 Cr ₹753 Cr ₹662 Cr ₹571 Cr
EPS ₹4.49 ₹9.03 ₹8.82 ₹8.86 ₹5.13 ₹9.28 ₹8.25 ₹7.17
Industry Peers & Returns1W1M1Y
Cipla 0.6% -6.1% 8.7%
SUN PHARMACEUTICAL INDUSTRIES 0.3% -3.9% 30.9%
DIVIS LABORATORIES -1.9% -4.6% 7.5%
DR REDDYS LABORATORIES 0.1% -6.7% -26.3%
GLAND PHARMA 3.4% -3.2% 11.2%
PIRAMAL ENTERPRISES 4.5% -14.9% 19.9%
CADILA HEALTHCARE -0.6% -5% -43.2%
TORRENT PHARMACEUTICALS 0.4% -8.8% -4.5%
ALKEM LABORATORIES 0.5% -13.6% -1.3%

Cipla Quarterly Revenues

Revenues
Q-o-Q

-3.99 %

Y-o-Y

14.19 %

Quarters Revenues % Change
Mar2022 ₹5,260 Cr
-3.99
Dec2021 ₹5,479 Cr
-0.74
Sep2021 ₹5,520 Cr
0.28
Jun2021 ₹5,504 Cr
19.49
Mar2021 ₹4,606 Cr
-10.88
Dec2020 ₹5,169 Cr
2.59
Sep2020 ₹5,038 Cr
15.93
Jun2020 ₹4,346 Cr -

Cipla Quarterly Operating Profit

Operating Profit
Q-o-Q

-39.10 %

Y-o-Y

-5.84 %

Quarters Operating Profit % Change
Mar2022 ₹750 Cr
-39.10
Dec2021 ₹1,231 Cr
0.39
Sep2021 ₹1,226 Cr
-8.89
Jun2021 ₹1,346 Cr
69.03
Mar2021 ₹796 Cr
-35.31
Dec2020 ₹1,231 Cr
4.62
Sep2020 ₹1,177 Cr
12.19
Jun2020 ₹1,049 Cr -
Operating Margins
Q-o-Q

-36.58 %

Y-o-Y

-17.58 %

Quarters Operating Margin% % Change
Mar2022 14.25%
-36.58
Dec2021 22.47%
1.17
Sep2021 22.21%
-9.16
Jun2021 24.45%
41.41
Mar2021 17.29%
-27.38
Dec2020 23.81%
1.97
Sep2020 23.35%
-3.23
Jun2020 24.13% -

Cipla Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-50.36 %

Y-o-Y

-9.34 %

Quarters Profit After Tax % Change
Mar2022 ₹377 Cr
-50.36
Dec2021 ₹759 Cr
6.59
Sep2021 ₹712 Cr
0.03
Jun2021 ₹712 Cr
71.31
Mar2021 ₹416 Cr
-44.78
Dec2020 ₹753 Cr
13.70
Sep2020 ₹662 Cr
15.82
Jun2020 ₹571 Cr -
PAT Margins
Q-o-Q

-48.30 %

Y-o-Y

-20.62 %

Quarters PAT Margin(%) % Change
Mar2022 7.16 %
-48.30
Dec2021 13.85 %
7.36
Sep2021 12.9 %
-0.23
Jun2021 12.93 %
43.35
Mar2021 9.02 %
-38.05
Dec2020 14.56 %
10.81
Sep2020 13.14 %
-0.08
Jun2020 13.15 % -

Cipla Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-50.28 %

Y-o-Y

-12.48 %

Quarters EPS % Change
Mar2022 ₹4.49
-50.28
Dec2021 ₹9.03
2.38
Sep2021 ₹8.82
-0.45
Jun2021 ₹8.86
72.71
Mar2021 ₹5.13
-44.72
Dec2020 ₹9.28
12.48
Sep2020 ₹8.25
15.06
Jun2020 ₹7.17 -

Cipla related INDICES

BSE Indices1W1M1Y
MFG 2.1% -6.9% 6.7%
S&P BSE HEALTHCARE 1.2% -9.9% -7.6%
S&P BSE LOW VOLATILITY 1.1% -5.2% -0.7%
S&P BSE ALLCAP 0.8% -9.3% 9.3%
S&P BSE GREENEX 0.7% -11.5% 8.8%
S&P BSE 500 0.6% -9.1% 8.7%
S&P BSE 250 LARGEMIDCAP 0.4% -8.8% 8.5%
S&P BSE 200 0.4% -8.8% 8.3%
S&P BSE LARGE MIDCAP 0.3% -8.9% 8.1%
S&P BSE 100 0.2% -8.6% 8.3%
NSE Indices1W1M1Y
NIFTY GROWTH SECTOR 15 3.6% -1.5% 5%
NIFTY QUALITY LOW-VOLATILTY 30 2.3% -3.7% 9.7%
NIFTY ALPHA QTY VAL LOW-VOL 30 2.2% -4.7% 10.4%
NIFTY ALPHA QTY LOW-VOLAT.30 1.7% -6.7% 8.5%
NIFTY PHARMA 1.4% -8.1% -9.3%
NIFTY500 MULTICAP 50:25:25 1.3% -10.2% 10.1%
NIFTY LARGE MIDCAP 250 1% -9.4% 9.7%
NIFTY 100 EQUAL WEIGHT 0.9% -10.4% 5.9%
NIFTY 500 0.6% -9.2% 8.7%
NIFTY HEALTHCARE 0.6% -10.1% -6.8%

You may also like the below Video Courses



SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z